John C. Martin
American chemist and businessman
- Fame39.8
- Momentum0.0
- Executives rank#85
Source-basedFalling
- Fame39.8
- Momentum0.0
- Executives rank#85
- Wikipedia327
Lived 1951–2021, aged 70United States
United StatesSummary
Updated 2026-06-16
John Charles Martin was an American billionaire businessman, and the former executive chairman (2016–2018) and CEO (1996–2016) of the American biotechnology company Gilead Sciences. He joined Gilead Sciences in 1990 as vice president for research and development. Gilead is known for developing drugs such as Atripla and commercializing Sovaldi (sofosbuvir) for the treatment of the liver virus hepatitis C. Martin is the recipient of a number of awards, including the Biotechnology Heritage Award (2017).
Gallery
Photos
1 image
Where to find them
Platforms
No platforms connected yet.
By the numbers
Score breakdown
The six component signals behind the Fame score, and their ranks across the leaderboards.
Fame
Falling39.8
Composite of search demand, mentions, audience & graph footprint.
Score components
Historical4.8
Source confidence30.0
Completeness70.0
Receipts
Sources
- جون س. مارتنLow confidencewikipedia · ar.wikipedia.org
- John C. Martin (Manager)Low confidencewikipedia · de.wikipedia.org
- John C. Martin (businessman)Low confidencewikipedia · en.wikipedia.org
Discover
You might know
Similar profiles worth watching
.jpg?width=1200)
.jpg?width=1200)
.jpg?width=1200)
.jpg?width=1200)
